ACTRN12610001001088
Completed
未知
A Pilot study, mandatory Venous Thromboembolism (VTE) Risk Assessment and Prophylaxis Implementation for cost effectively improving VTE outcomes in hospitalized medical patients
Clinical Trials Unit, St George Hospital0 sites360 target enrollmentNovember 17, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Clinical Trials Unit, St George Hospital
- Enrollment
- 360
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Hospital medical inpatient admissions
Exclusion Criteria
- •Patients admitted to psychatric, surgical and Paediatic wards,
- •Patients discharged on the day of admission.
- •Patients admitted for Deep Vein Thrombosis or Pulmonary Embolism treatment.
- •Patient or next of Kin refuses consent.
- •Patients currently on therapeutic anticoagulants. Warfarin Intravenous Heparin, fonadaprinux, rivaroxaban,darbigatran, and Aspirin 360mg/day or higher
- •Patients in palliative care, intensive care units and high dependancy units
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Validation study of incidence of thromboembolism in lung cancer patientson-small cell lung cancer, small cell lung cancerJPRN-UMIN000053138Shimane University Faculty of Medicine300
Completed
Not Applicable
Prospective observational study of venous thromboembolism in advanced pancreatobiliary cancerBiliary tract cancer Pancreatic cancerJPRN-UMIN000040965ational Hospital Organization Kyushu Cancer Center200
Recruiting
Not Applicable
Prospective study of venous thromboembolism and bleeding complications associated with primary and secondary VTE prevention during pregnancy and postpartum in women with previous VTE, hereditary thrombophilia or antiphospholipid syndromeO22.3D68.5Deep phlebothrombosis in pregnancyPrimary thrombophiliaDRKS00028688niversitätsklinikum RegensburgUniversitäres Gefäßzentrum - Bereich Angiologie1,000
Completed
Not Applicable
Assessment of venous thromboembolic disease (VTE) in oncology and haematology patients who presented to the Launceston General Hospital for treatment of their malignant disordervenous thromboembolic diseaseMalignant disorderBlood - Haematological diseasesCancer - Any cancerACTRN12611000762954Clifford Craig Medical Trust Fund766
Completed
Not Applicable
Assessment of venous thromboembolic disease (VTE) in medical patients who presented to the Launceston General Hopspital (LGH)Venous thromboembolism (VTE) among medical patients.Blood - Clotting disordersACTRN12611001255976Clifford Craig Medical Trust Fund1,200